Medicare Enrolled
Dr. Anthony Davis, M.D.
Family Medicine · Lindale, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Davis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Davis? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Davis
Dr. Anthony Davis is a family medicine in Lindale, TX, with 19 years in practice. Based on federal Medicare data, Dr. Davis performed 26,933 Medicare services across 12,679 unique beneficiaries.
Between the years covered by Open Payments, Dr. Davis received a total of $18,489 from 64 pharmaceutical and/or device companies across 738 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Davis is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 0% volume in TX$ $18,489 industry payments
Medicare Practice Summary
Medicare Utilization ↗26,933
Medicare services
Top 0% in TX for family medicine
12,679
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,418 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month | 1,970 | $42 | $70 |
| Blood draw (venipuncture) | 1,309 | $8 | $10 |
| Office visit, established patient (30-39 min) | 1,276 | $84 | $190 |
| Comprehensive metabolic blood panel | 1,243 | $10 | $38 |
| Complete blood count (CBC) with differential | 1,240 | $8 | $28 |
| Free thyroxine (T4) test | 1,165 | $9 | $26 |
| Thyroid stimulating hormone (TSH) test | 1,159 | $16 | $44 |
| Lipid panel (cholesterol and triglycerides) | 1,120 | $13 | $33 |
| Vitamin D level test | 1,097 | $29 | $75 |
| Vitamin B-12 level test | 1,042 | $15 | $36 |
| Thyroid hormone, t3 measurement, free | 945 | $17 | $40 |
| C-reactive protein test (inflammation marker) | 920 | $5 | $19 |
| Steroid injection (triamcinolone) | 844 | $1 | $8 |
| Hemoglobin A1c test (diabetes monitoring) | 801 | $10 | $27 |
| Creatine kinase (cardiac enzyme) level, total | 788 | $6 | $21 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 776 | $4 | $16 |
| Insulin measurement, total | 637 | $11 | $30 |
| Ceftriaxone antibiotic injection | 608 | $0 | $6 |
| Dexamethasone injection (steroid) | 554 | $0 | $2 |
| Ferritin level test (iron stores) | 536 | $13 | $35 |
| Iron binding capacity test | 525 | $9 | $25 |
| Iron level test | 521 | $6 | $21 |
| Urine microalbumin test (kidney screening) | 516 | $6 | $20 |
| Testosterone (hormone) level, total | 452 | $25 | $56 |
| Measurement of total estradiol (hormone) | 448 | $27 | $60 |
| Gonadotropin, follicle stimulating (reproductive hormone) level | 354 | $18 | $43 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | 299 | $30 | $68 |
| Manual urinalysis test with examination using microscope, non-automated | 291 | $4 | $15 |
| Progesterone (reproductive hormone) level | 251 | $20 | $47 |
| Office visit, established patient (20-29 min) | 239 | $59 | $135 |
| Ultrasound of both sides of head and neck blood flow | 198 | $133 | $476 |
| Advance care planning consultation, first 30 min | 193 | $55 | $95 |
| Annual wellness visit, follow-up | 187 | $124 | $160 |
| Annual depression screening | 181 | $18 | $22 |
| Nursing facility visit, low complexity | 176 | $56 | $105 |
| Echocardiogram, transthoracic | 164 | $137 | $485 |
| Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 159 | $139 | $260 |
| Prostate cancer screening; prostate specific antigen test (psa) | 155 | $19 | $52 |
| Drug screening test | 127 | $61 | $100 |
| Detection test by immunoassay with direct visual observation for influenza virus | 120 | $16 | $35 |
| Injection, ketorolac tromethamine, per 15 mg | 116 | $0 | $2 |
| Nursing facility visit, moderate complexity | 109 | $81 | $120 |
| Chest X-ray, 2 views | 102 | $23 | $48 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 82 | $41 | $75 |
| Natriuretic peptide (heart and blood vessel protein) level | 78 | $38 | $70 |
| PSA test (prostate cancer screening) | 66 | $18 | $52 |
| Bone density scan (DEXA) | 55 | $36 | $180 |
| Transitional care management services for problem of high complexity | 54 | $208 | $300 |
| Electrocardiogram (EKG), 12-lead | 53 | $10 | $42 |
| Regadenoson injection (Lexiscan) for heart stress test | 44 | $39 | $75 |
| Testosterone (hormone) level, free | 42 | $25 | $55 |
| New patient office visit (30-44 min) | 41 | $62 | $170 |
| Uric acid level test | 40 | $4 | $18 |
| Parathyroid hormone level test | 38 | $40 | $83 |
| Ultrasound study of arm and leg arteries | 34 | $57 | $210 |
| Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | 32 | $102 | $190 |
| 3D screening mammography (tomosynthesis) | 30 | $51 | $150 |
| Screening mammography | 30 | $122 | $230 |
| X-ray of lower and sacral spine, 2-3 views | 26 | $30 | $60 |
| Limited ultrasound scan of abdomen | 22 | $47 | $287 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 21 | $16 | $32 |
| Shoulder X-ray, 2+ views | 18 | $21 | $61 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 18 | $136 | $410 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 17 | $316 | $665 |
| Urinalysis, manual | 17 | $3 | $12 |
| Stool analysis for blood, by fecal hemoglobin determination by immunoassay | 17 | $16 | $45 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 17 | $47 | $194 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 16 | $31 | $55 |
| X-ray of upper spine, 2-3 views | 14 | $21 | $74 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 14 | $259 | $634 |
| Mri scan of arm joint without contrast | 13 | $161 | $816 |
| Ultrasound of leg arteries or artery grafts | 13 | $163 | $600 |
| X-ray of abdomen, 1 view | 12 | $17 | $45 |
| Amylase (enzyme) level | 12 | $6 | $21 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 12 | $18 | $28 |
| Complete ultrasound scan of abdomen | 11 | $71 | $376 |
| Lipase (fat enzyme) level | 11 | $7 | $24 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
9.2% medium
90.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,489
Total received (2018-2024)
Avg $2,641/year across 7 years
Top 1% in TX for family medicine
64
Companies
738
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,177 (60.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,338 (23.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,975 (16.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,643
2023$4,880
2022$1,657
2021$1,882
2020$4,268
2019$2,665
2018$1,495
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$4,808
Amgen Inc.
$3,582
Novo Nordisk Inc
$1,067
Lilly USA, LLC
$905
AstraZeneca Pharmaceuticals LP
$744
Boehringer Ingelheim Pharmaceuticals, Inc.
$710
Amarin Pharma Inc.
$649
Novartis Pharmaceuticals Corporation
$576
Kowa Pharmaceuticals America, Inc.
$463
Teva Pharmaceuticals USA, Inc.
$416
Medicure Pharma Inc.
$302
AbbVie Inc.
$295
Bayer HealthCare Pharmaceuticals Inc.
$288
Bayer Healthcare Pharmaceuticals Inc.
$249
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$232
Takeda Pharmaceuticals U.S.A., Inc.
$208
Janssen Pharmaceuticals, Inc
$194
AbbVie, Inc.
$169
Sunovion Pharmaceuticals Inc.
$164
Avanir Pharmaceuticals, Inc.
$154
SANOFI-AVENTIS U.S. LLC
$144
ABBVIE INC.
$139
GlaxoSmithKline, LLC.
$137
Merck Sharp & Dohme Corporation
$129
Exact Sciences Corporation
$126
Astellas Pharma US Inc
$118
IDORSIA PHARMACEUTICALS US INC
$115
Biohaven Pharmaceuticals, Inc.
$100
Biohaven Pharmaceutical Holding Company Ltd.
$92
Smith+Nephew, Inc.
$82
Otsuka America Pharmaceutical, Inc.
$81
Antares Pharma, Inc.
$77
Merz North America, Inc.
$75
Smith & Nephew, Inc.
$74
Phathom Pharmaceuticals, Inc.
$72
Shire North American Group Inc
$60
Eisai Inc.
$58
Lundbeck LLC
$57
Mylan Specialty L.P.
$56
Supernus Pharmaceuticals, Inc.
$39
Neurocrine Biosciences, Inc.
$36
Clarus Therapeutics Inc.
$34
Ultragenyx Pharmaceutical Inc.
$30
Nalpropion Pharmaceuticals LLC
$29
Nevro Corp.
$28
TherapeuticsMD, Inc.
$28
Orexigen Therapeutics, Inc.
$26
Arbor Pharmaceuticals, Inc.
$25
ARBOR PHARMACEUTICALS, INC.
$24
Axsome Therapeutics, Inc.
$22
ABIOMED
$21
Inspire Medical Systems, Inc.
$20
Paratek Pharmaceuticals, Inc.
$18
Corium, LLC
$18
Noden Pharma USA Inc
$17
Esperion Therapeutics, Inc.
$17
Allergan, Inc.
$16
EISAI INC.
$15
Aytu BioScience, Inc
$14
Boston Scientific Corporation
$14
Xeris Pharmaceuticals, Inc.
$13
Acerus Pharmaceuticals Corporation
$12
Athena Bioscience, LLC
$9
Medline Industries, Inc.
$0
Top 3 companies account for 51.2% of total payments
Associated products mentioned in payments ›
AIMOVIG · ANNOVERA · ANORO · APTIOM · AREXVY · AUSTEDO · Aimovig · Amitiza · Androgel · Austedo XR · Auvelity · Azstarys · BASAGLAR · BIJUVA · BREZTRI · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · CREON · Cologuard Collection Kit · Creon · Crysvita · Dayvigo · Dexilant · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · FARXIGA · FASENRA · Grafix PL PRIME · HMG-CoA reductase inhibitor. · Horizant · INGREZZA · INSPIRE · INVOKANA · Impella · JANUVIA · JARDIANCE · JATENZO · KEVEYIS · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · LIVALO · LONHALA MAGNAIR · LYRICA · Livalo · MOUNJARO · MYDAYIS · NEXLETOL · NOCDURNA · NUEDEXTA · NURTEC ODT · NUZYRA · Natesto · Nuedexta · OTREXUP · Omnia · Ongentys · Otezla · Ozempic · PREMARIN · Prolia · QDOLO · QELBREE · QULIPTA · QUVIVIQ · QVAR · REXULTI · REYVOW · REZUM · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SOLIQUA · SYMBICORT · Santyl · Saxenda · TEKTURNA · TLANDO · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TZIELD · Tresiba · Trintellix · UBRELVY · VOQUEZNA · VRAYLAR · VYEPTI · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xeomin · YUPELRI · Yupelri · ZEPBOUND · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in TX.
Equivalent to $69 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
162
Per 100K population
68.1
County median income
$71,923
Nearest hospital
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT TYLER
15.2 mi
15.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Davis is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (low-engagement, top 1%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Davis experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Davis performed 1,970 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Davis receive payments from pharmaceutical companies?
Yes. Dr. Davis received a total of $18,489 from 64 companies across 738 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Davis's costs compare to other family medicines in Lindale?
Dr. Davis's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Davis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Lindale
Browse family medicines in Lindale ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology